Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

D-serine and Cognitive Remediation in Schizophrenia: Open Label Pilot

NCT02156908 is registered in ClinicalTrials.gov with Nathan Kline Institute for Psychiatric Research as lead sponsor.

NCT NCT02156908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02156908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
D-serine and Cognitive Remediation in Schizophrenia: Open Label Pilot
Lead sponsor
Nathan Kline Institute for Psychiatric Research
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2014
Completion date
December 31, 2015
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia